Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 9, 2014 - Issue
Submit an article Journal homepage
81
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease

Koichi Nishimura1 Department of Pulmonary Medicine, National Center for Geriatrics and Gerontology, Obu, JapanCorrespondence[email protected]
,
Takashi Nishimura2 Kyoto-Katsura Hospital, Kyoto, Japan
,
Katsuya Onishi3 Onishi Heart Clinic, Tsu, Japan
,
Toru Oga4 Department of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
,
Yoshinori Hasegawa5 Division of Respiratory Medicine, Department of Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan
&
Paul W Jones6 Division of Clinical Science, St George’s Hospital Medical School, London, England
Pages 155-162 | Published online: 05 Feb 2014

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Juan Jose Soler-Cataluña & Jose Luis Lopez-Campos. (2022) COPD Exacerbation Syndrome: The Spanish Perspective on an Old Dilemma. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 3139-3149.
Read now
Ji-Yong Moon, Fernando Sergio Leitao Filho, Kimeya Shahangian, Hiroto Takiguchi & Don D. Sin. (2018) Blood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD). Expert Review of Proteomics 15:11, pages 923-935.
Read now

Articles from other publishers (20)

Bodrug Nicolae & Luca Ecaterina. (2022) Natriuretic peptides in elderly patients with chronic obstructive pulmonary disease. The Egyptian Journal of Bronchology 16:1.
Crossref
Manash Pratim Pathak, Aparoop Das, Pompy Patowary & Pronobesh Chattopadhyay. (2020) Contentious role of ‘Good Adiponectin’ in pulmonary and cardiovascular diseases: Is adiponectin directed therapy a boon or a bane?. Biochimie 175, pages 106-119.
Crossref
Eskandarain Shafuddin, Catherina L. Chang, Manisha Cooray, Christine M. Tuffery, Sandra J. Hopping, Glenda D. Sullivan, Glenn A. Jacobson & Robert J. Hancox. (2018) Changes in biomarkers of cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease. Respiratory Medicine 145, pages 192-199.
Crossref
Saraschandra Vallabhajosyula, Toufik Mahfood Haddad, Pranathi R. Sundaragiri, Anas A. Ahmed, Muhammad Sarfraz Nawaz, Hamza A. A. Rayes, Harish C. Devineni, Arun Kanmanthareddy, Dustin A. McCann, Christopher S. Wichman, Ariel M. Modrykamien & Lee E. Morrow. (2016) Role of B-Type Natriuretic Peptide in Predicting In-Hospital Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Preserved Left Ventricular Function: A 5-Year Retrospective Analysis. Journal of Intensive Care Medicine 33:11, pages 635-644.
Crossref
Wassim W. Labaki, Meng Xia, Susan Murray, Jeffrey L. Curtis, R. Graham Barr, Surya P. Bhatt, Eugene R. Bleecker, Nadia N. Hansel, Christopher B. Cooper, Mark T. Dransfield, J. Michael Wells, Eric A. Hoffman, Richard E. Kanner, Robert PaineIIIIII, Victor E. Ortega, Stephen P. Peters, Jerry A. Krishnan, Russell P. Bowler, David J. Couper, Prescott G. Woodruff, Fernando J. Martinez, Carlos H. Martinez & MeiLan K. Han. (2018) NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort. Respiratory Medicine 140, pages 87-93.
Crossref
Nidhi Gupta, Jignesh Vanane, Gajendra Dubey, Ravi Varmore & Pankaj Garg. (2018) PLASMA BRAIN NATRIURETIC PEPTIDE LEVELS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS WITHOUT PULMONARY HYPERTENSION. Journal of Evidence Based Medicine and Healthcare 5:25, pages 1926-1929.
Crossref
Morten Kraen, Sophia Frantz, Ulf Nihlén, Gunnar Engström, Claes-Göran Löfdahl, Per Wollmer & Magnus Dencker. (2018) Brain natriuretic peptide levels in middle aged subjects with normal left ventricular function in relation to mild-moderate COPD. The Clinical Respiratory Journal 12:3, pages 1061-1067.
Crossref
Nathaniel M. Hawkins, Amit Khosla, Sean A. Virani, John J. V. McMurray & J Mark FitzGerald. (2017) B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review. BMC Pulmonary Medicine 17:1.
Crossref
Randa Salah El Deen Mohammad, Nabila Ibrahim Laz, Mahmoud Mohamed Elbatanouny, Khalid Refaat A. Elmageed & Hebatullah Kamal Ebraheem Taha. (2017) Effect of diuretics on the plasma brain natriuretic peptide (BNP) level in patients with an acute exacerbation of COPD. Egyptian Journal of Chest Diseases and Tuberculosis 66:3, pages 401-404.
Crossref
Yu-wei Roy Chen, Virginia Chen, Zsuzsanna Hollander, Jonathon A. Leipsic, Cameron J. Hague, Mari L. DeMarco, J. Mark FitzGerald, Bruce M. McManus, Raymond T. Ng & Don D. Sin. (2017) C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizations. PLOS ONE 12:3, pages e0174063.
Crossref
Ahmed G. El Gazzar, Nabil A. Hibah, Tahany M. Gouda, Amira I. Mansour & Mohamad Y. Sabry. (2017) Plasma brain natriuretic peptide levels in COPD without pulmonary hypertension. Egyptian Journal of Chest Diseases and Tuberculosis 66:1, pages 49-54.
Crossref
Luigino Calzetta, Augusto Orlandi, Clive Page, Paola Rogliani, Barbara Rinaldi, Giuseppe Rosano, Mario Cazzola & Maria Gabriella Matera. (2016) Brain natriuretic peptide: Much more than a biomarker. International Journal of Cardiology 221, pages 1031-1038.
Crossref
Yu-Wei Roy Chen, Janice M. Leung & Don D. Sin. (2016) A Systematic Review of Diagnostic Biomarkers of COPD Exacerbation. PLOS ONE 11:7, pages e0158843.
Crossref
Robert Marcun, Ivan Stankovic, Radosav Vidakovic, Jerneja Farkas, Sasa Kadivec, Biljana Putnikovic, Ivan Ilic, Aleksandar N. Neskovic & Mitja Lainscak. (2015) Prognostic implications of heart failure with preserved ejection fraction in patients with an exacerbation of chronic obstructive pulmonary disease. Internal and Emergency Medicine 11:4, pages 519-527.
Crossref
Meredith L. Howard & Ashley H. Vincent. (2016) Statin Effects on Exacerbation Rates, Mortality, and Inflammatory Markers in Patients with Chronic Obstructive Pulmonary Disease: A Review of Prospective Studies. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36:5, pages 536-547.
Crossref
Martin I MacDonald, Eskandarain Shafuddin, Paul T King, Catherina L Chang, Philip G Bardin & Robert J Hancox. (2016) Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease. The Lancet Respiratory Medicine 4:2, pages 138-148.
Crossref
Kittipong Maneechotesuwan, Adisak Wongkajornsilp, Ian M. Adcock & Peter J. Barnes. (2015) Simvastatin Suppresses Airway IL-17 and Upregulates IL-10 in Patients With Stable COPD. Chest 148:5, pages 1164-1176.
Crossref
Heikki O. Koskela, Päivi H. Salonen, Jarkko Romppanen & Juha Hartikainen. (2015) Plasma amino-terminal pro B-type natriuretic peptide as a predictor of late cardiovascular mortality in patients with acute lung disorders: a prospective, observational cohort study. ESC Heart Failure 2:2, pages 69-75.
Crossref
Janice M. Leung & S.F. Paul Man. (2014) A sum greater than its parts. European Respiratory Journal 44:6, pages 1394-1396.
Crossref
Robert P Young, Raewyn J Hopkins & Alvar Agusti. (2014) Statins as adjunct therapy in COPD: how do we cope after STATCOPE?. Thorax 69:10, pages 891-894.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.